{"doi":"10.1002/adaw.33311","title":"More than 50% of patients treated with methadone or buprenorphine drop out","abstract":"<jats:p>A recent study conducted in Canada found that doses that are too low can cause patients to drop out of treatment with methadone or buprenorphine. For the study, researchers used data on all individuals in the province of British Columbia who received treatment for opioid use disorder (OUD) with methadone (73.9% of patients), buprenorphine (24.7%) or slow‐release morphine (1.4%), which is legal for treatment in Canada.</jats:p>","journal":"Alcoholism &amp; Drug Abuse Weekly","year":2022,"id":37340,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":187330,"name":"Alison Knopf","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24523987","pmcid":null,"openalex_id":"https://openalex.org/W4205298653","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.0044249,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/adaw.33311","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/adaw.33311","host_type":"publisher"},{"url":"https://doi.org/10.1002/adaw.33311","host_type":"journal"}],"fields_of_study":["Opioid Use Disorder Treatment","Substance Abuse Treatment and Outcomes","Pain Management and Opioid Use"],"mesh_terms":[],"keywords":["Buprenorphine","Methadone","Opioid use disorder","Medicine","Opioid","Drop out","Anesthesia","Morphine","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-10T19:12:39.870033Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}